Table 1.
Patient Demographics and Clinical Characteristics
| Total population (n = 72) | Low POD1 PTH (n = 8) | Normal POD1 PTH (n = 64) | |
|---|---|---|---|
| Sex, n (%) | |||
| Female | 56 (78%) | 7 (88%) | 49 (77%) |
| Male | 16 (22%) | 1 (13%) | 15 (23%) |
| Race/ethnicity, n (%) | |||
| White | 51 (71%) | 4 (50%) | 47 (73%) |
| Non-white | 21 (29%) | 4 (50%) | 17 (27%) |
| Indication for surgery, n (%) | |||
| Graves' disease | 21 (29%) | 2 (25%) | 19 (30%) |
| Papillary thyroid carcinoma | 13 (18%) | 2 (25%) | 11 (17%) |
| Other thyroid cancer | 15 (21%) | 1 (13%) | 14 (22%) |
| Toxic/nontoxic thyroid nodule | 20 (28%) | 2 (25%) | 18 (28%) |
| Hashimoto's thyroiditis | 3 (4%) | 1 (13%) | 2 (3%) |
| Surgical procedure, n (%) | |||
| Total thyroidectomy | 58 (81%) | 4 (50%) | 54 (84%) |
| Total thyroidectomy with lymph node dissection | 10 (14%) | 3 (38%) | 7 (11%) |
| Completion thyroidectomy | 4 (6%) | 1 (13%) | 3 (5%) |
| Age, mean ± SD, years | 48.8 ± 13.2 | 43.9 ± 11.6 | 49.4 ± 13.3 |
| Body mass index, mean ± SD, kg/m2 | 33.6 ± 8.4 | 31.9 ± 8.0 | 33.8 ± 8.5 |
| No. of PGs per patient, mean ± SD | 3 ± 0.9 | 3.4 ± 0.7 | 2.9 ± 0.9 |
PG, parathyroid gland; POD1, postoperative day 1, PTH, parathyroid hormone; SD, standard deviation.